The association between BRAF (B-Raf Proto-Oncogene, Serine/Threonine Kinase) and Lung Cancer Susceptibility 3 is well established and manually curated, with its 2 contributing sources — 1 of them expert-curated — recording likely-pathogenic variants.
Sources2
Clinical variants6
Symptoms0
Compounds0
Trials0
Publications8
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.